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A New Molecular Assay with High Sensitivity Provides Evidence for Systemic Involvement in Early 
Cutaneous T-Cell Lymphoma 
Veelken et al (p. 889) have modified a recently developed assay, a 
polymerase chain reaction (PCR)-based RNAse protection assay 
(PCR/RPA) that may be useful in the staging of cutaneous T -cell 
lymphoma (CTCL). T lus assay is based on the rapid detection of 
clonal T -cell receptor gamma chain gene rearrangements. Previ-
ously, diagnostic techniques involved Southern blotting of genomic 
DNA isolated from biopsy specimens. With this method, lymphoid 
malignancies could be detected as a clonal excess of a specific type 
of antigen receptor gene rcarrangcmcnt over polyclonal rcarrange-
ments. The in troduction of amplification of rearranged antigen 
receptor gcnes by the PCR allowed ana lysis of very small samples. 
Using PCR ampli fication in addition to RNAse protection (PCRI 
RPA) , Veclken and co-workers arc able to detect a single malig-
nant cell in 105 nOrl1lal bone marrow ceLIs , making this diagnostic 
assay tenfold more sensitive. In this study, the authors test w hether 
uSillg tlus scnsitive molecular assay improves staging of a solid 
lymphoid malignancy. T hey compare thrce m ethods for the mo-
lecular detection oflymphomatous involvement in biopsies, includ-
ing a variety of involved aJld uninvolved areas , fi·om patients with 
CTCL including one patien t with stagc 1 A . They report that 
PCR/RPA was able to detect malignant cell s in 100% of the 
biopsies, w hereas the other two m ethods failed to detect malignant 
cells in about 40%. T hus, PCR/ RPA may bc useful in detecting 
early recurrence during clinical remission. 
Autoantibodies Agairlst Desmoglein 1 Cause Blisters in Pemphigus Foliaceus 
Amagai ct al (p. 895) provide new evidence that aJltibodies to the 
desmoso mal cadherin desmoglein 1 (Dsgl) are pathogenic in 
pemphigus foliaccus. Both pemphigus vulgaris and pemplugus 
foliaceus involve circulating IgG antibod.ies that bind to stratified 
epithelia. In addition, antibodies from pemplugus patients can 
induce the disease phenotype (i.e., blisters) in skin in o rgan culture 
and in neonatal mice. cDNA cloning has revealed that ilie antigens 
are members of tlle desmoglein subf.1mily of the cadherin super-
gene fami ly, and these cadherins have been designated desmoglein 
3 (Dsg3) in pemphigus vulgaris and desmoglein 1 (Dsgl) in 
pemphigus foliaceus. 
In previous studies, the authors have found that recombinant 
pemphigus vulgaris antigen expressed in bacteria was recognized by 
60% of sera from patients, and autoantibodies recognizing the 
expressed protein were able to produce blisters in neonatal mice. 
Using a similar approach to pemphigus fo liaceus, the authors 
engineered a secreted form of Dsgl and expressed the protein in a 
baculovirus vector. Their results demonstrate that antibodies spe-
cificaJly directed against the Dsgl extracellular domain cause 
characteristic blistering at the granular level of tlle epidermis in 
neonata l mice, a model for the disease. In addition, the baculopro-
tein harvested fi·om conditioned medium was able to absorb 
immunoreactivity agalllst the keratinocyte cell surface in 100% of 
pemphigus foliaceus sera tested. These data provide additional md 
more direct evidence that anti-Dsgl antibodies are the causative 
agent in pemphigus folia ceus and show that the pathogenic aJlti-
bodies are directed against tll e extracellular domain. 
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Small Proline-Rich Proteins (SPRRs) Are Differentially Regulated and Expressed 
Hohl ct at (p. 902) show that the m ul tigene fami ly of SPRRs are 
precursor proteins for the cornifi ed cell envelope and that these 
proteins are differentially expressed in stratifi ed squa mou s epithelia 
and in cu lture. The formation of this cell envelope requires 
cross-linking of specific proteins into the in soluble gran ul ar ce ll 
envelope by transglu taminases. SPRR.s are a fam il y of sm all 
proline-rich proteins expressed in terminally differentiatin g hu man 
epitheli al ce lls have been localized to a segm ent of chromosome 
1q21 close to the loricrin and involucrin gene, two other compo-
nents of the cell envelope . Using m o nospecific polyclonal antibod-
ies, Hohl and co-workers demonstrate that SPPRs are restricted to 
terminally differentiating squamous epith elia cells and that reactiv-
ity to SPPR antibodies decreases in cells with a mature cell 
envelope. Furthermo re, they show that inhibi ting transglu taminase 
activity causes SPRR.s to accumu late in cultured differe n tiating 
keratinocytes, suggesting th at SPRRs arc transglu taminase sub-
strates, and that SPRR.1, SPRR.2, and SPRR3 proteins are ex-
pressed in different areas of skin, tongue, and other oral epithelia. 
Psoriatic epidermis exhibits an increased expression of SPIU~1 and 
SPIUU, bu t not SPIU~3, w hereas retinoic acid down- regu lates 
SP~2 and SPIU~3, but hardl y decreases SPRRl at all. These data 
suggest that m embers of the SPRR multigene family evolved to 
serve as specialized precursors for cornifi ed cell envelopes of 
diffe ren t types of stratified epithelia. 
Keratin 20 Is a Specific Marker for Merkel Cells 
Tn this issue, Moll and colleagues (p . 910) report that antibodies to 
keratin 20 (K20) specifically stain Merkel cells in human, pig, and 
mouse epidermis and hair follicles . Merkel cells are the neuroen-
docrine cells of the epiderm is and are not easil y distingu ished from 
epiderma l cell s by routine histology . In adu lt and late stage feta l 
epidermis it has been possible to identify Merkel cells by staining 
with antibodies to the simple epithelial keratins 8, 18, or 19 or with 
the neurosecretory marker chro mogranin A (CgA), which shows a 
small granu lar sta in in the cytoplasm. T he keratin antibod ies also 
stain early stage fetal epidermal cell s and the periderm, however, 
whi ch makes determination of the origin of Merkel cells impossi-
ble. Additiona lly, these simple epithelia l keratins stain other cells in 
the outer root sheath of hair fo lli cles, hampering the identification 
of Merkel cell s in follicular epithelium. Mo ll and co-workers 
establish that the type I keratin 20 is a specific marker for Merke l 
cell s by double-labe ling techni q ues with either CgA o r the simple 
keratins, or w ith K5 or K14, keratin markers for epidermal cells. 
T hey fmd that K20 stains on ly individual dendritic ce ll s in the basal 
layer of the outer root sheath of hair fo llicles, whereas K8, KI8, and 
K 19 also stain subsets of epidermal cells. T hey also show that K20 
stains only cell s in epidermis that arc not stained by K5 or K14. In 
addjtion , K20 stains all the dendritic cells in early stage fetal 
epidermis that CgA stained plu s a few more, indicating that CgA 
was not staining a ll the Merkel cells. Fina lly, the. authors show that 
Merkel cell s as detected by K20 do not sta in w ith antibodies to 
various neurofi lament proteins, indicating that Merkel cells conta in 
no n eurofi laments. 
Resistance to Mitotoxin Is Caused by Down-Regulating Receptors for Basic Fibroblast Growth Factor 
Davol et at (p. 96) report that autocrin e down-regu lation of basic 
fibrob last growth factor (bFGF) receptors is th e mechani sm by 
w hi ch melanoma cells develop resistance to a " mitotoxin " in a 
human melanoma cell lin e and that this resistance ca n be circum-
vented by treatment w ith suramin . Melanoma can be treated with 
an engineered molecu le combining a g rowth factor (mitogen) and 
toxin ("m itotoxin"). One type of m itotoxin, bFGF-saporin , at-
taches to a ce ll surface receptor, the bFGF receptor, via the natural 
ligand, bFGF, and is in terna lized by endocytosis, at which po in t the 
saporin part of the molecule, the toxin , inhib its protein synthesis, 
ultimately causing death of the melanoma cell . T hi s approach is 
useful in treatment of m elanoma, in part beca use norm al nonpro-
liferating cell s express a limi ted number of bFGF receptors, whi le 
melanoma cell s express high affin ity receptors for bFGF. Effective-
ness of the treatmen t m ay be limited, however, because res istant 
tumor cells eventua lly emerge, and approximately 40'Yo of these 
tumors are resistant to further therapy with bFGF-saporin . bFGF-
saporin is moving closer to clinical tria ls. T he auth'ors report that 
subpop ulations of human melanoma cell s escape bFGF-sapol'in 
targeting because an autocrine bFGF loop downregulates bFGF 
receptors, reducing the number of receptors ava ilab le for mi totoxin 
binding and allowing these cells to survive. T hey dem onstrate th at 
thjs mode of resistance can be prevented by pretreatment w ith 
suramin or with neurta liz ing antibodies to FGF, which block the 
amocrine loop and upregulate FGF receptors. 
TNFa Is Involved in the Formation of Apoptopic Cells After UVB Irradiation 
Schwarz e/ at (p. 922) demonstrate tha t tum or necrosis factor-a 
(TNF-a) is in volved in UVB-mediated apoptosis of keratinocytes 
but is not suffi cient by itself to induce the fo rmation of sunburn 
ce lls. Apoptosis is a "su icide program" involving active processes 
on the part of the cell such as protein syn thesis and activation of 
kinases. It can be a response to a sublethal stimulu s that by itse lf 
does not cause cell death. U ltravio let radiation (UVB) ca n be such 
a stimulus and results in the formation of apoptopic keratinocytes 
called sunb urn ce ll s. During UVB irradiation keratinocytes have 
been shown to re lease TN Fa, a cytokine known to cause apoptosis 
in cells. To test whether TNFa is the d irect ca use of sunburn cell s 
in ixradia ted keratinocytes, the authors examined UVE-irradiated 
cul tu red normal human keratinocytes and HaCaT cells for apop-
tos is. T hey fou nd that UVB induced apoptosis in a dose-dependent 
m an ne r and that antibody to human T N Fc~ added to the cul ture 
m edium immediately afte r irradiation reduced apoptosis. To test for 
TNfa involvement i/l /lillO, they irradiated Ea lb/c m ice and injected 
antibody to T NFa immediately after UVB treatment. T his pro-
duced signifi ca nt red uction in the number of sunburn cells, but not 
all cells w ere rescued frol11 apoptosis, indicating that UVE-induced 
apoptosis and formation of sunburn cells is not ca used solely by 
TNfa but is proba bl y l11ul tifactoria l. 
